Skip to content

Apogee Enterprises APOG Vested, grant-date fair value

Vested, grant-date fair value at other companies

Constellium logo
ConstelliumCSTM
$26M+18.2%

Other financials

Income statement

See full
Revenue$351.4M+1.6%
Gross profit$78.7M+5.6%
Operating income$25.8M+320%
Net income$16.6M+569%
EPS (diluted)$0.78+500%

Balance sheet

See full
Cash & equivalents$39.5M-4.6%
Total debt$286.4M-18.6%
Total equity$511.8M+4.9%
Total assets$1.1B-4.5%

Cash flow

See full
Operating cash flow$55.8M+85.9%
CapEx$9.0M-17.5%
Free cash flow$46.9M+145%

Valuation

See full
Market cap$895.89M+8.9%
Enterprise value$1.14B+0.8%
P/E16.6×+6.9×
P/S0.6×0.0×

Profitability

See full
Gross margin22.7%-3.7pp
Operating margin6%-2.7pp
Net margin3.9%-2.4pp
FCF margin6.8%+0.2pp

Returns & leverage

See full
Return on equity10.8%-6.9pp
Debt / equity0.6×-0.2×
Current ratio1.6×+0.1×

Where this comes from

Reported directly by Apogee Enterprises in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue.

The official record: Apogee Enterprises’s 10-K, filed April 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Apogee Enterprises's vested, grant-date fair value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Apogee Enterprises's vested, grant-date fair value?
Apogee Enterprises (APOG) reported vested, grant-date fair value of $3.2M in Q1 2026.
How has Apogee Enterprises's vested, grant-date fair value changed year-over-year?
Apogee Enterprises's vested, grant-date fair value increased by 28.0% year-over-year, from $2.5M to $3.2M.
What is the long-term trend for Apogee Enterprises's vested, grant-date fair value?
Over 2 years (2024 to 2026), Apogee Enterprises's vested, grant-date fair value has grown at a 48.6% compound annual growth rate (CAGR), from $5.8M to $12.8M.
What does vested, grant-date fair value mean?
Reflects the total grant-date fair value of equity-based awards, such as restricted stock units, that have vested during the period. This metric provides insight into the company's long-term incentive structure and the non-cash compensation expense associated with employee retention.